The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 11, 2018
Filed:
Mar. 22, 2016
Applicant:
Univerza V Ljubljani, Ljubljani, SI;
Inventors:
Boris Brus, Vojnik, SI;
Urban Kosak, Ljubljana, SI;
Damijan Knez, Vuzenica, SI;
Nicolas Coquelle, Grenoble, FR;
Jacques-Philippe Colletier, Grenoble, FR;
Stanislav Gobec, Ljubljana, SI;
Assignee:
UNIVERZA V LJUBJIANI, Ljubliana, SI;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); C07D 211/06 (2006.01); C07D 211/28 (2006.01); A61K 31/4523 (2006.01); A61K 31/453 (2006.01); A61K 31/4709 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 211/26 (2006.01);
U.S. Cl.
CPC ...
C07D 211/28 (2013.01); A61K 31/445 (2013.01); A61K 31/453 (2013.01); A61K 31/4523 (2013.01); A61K 31/4709 (2013.01); C07D 211/26 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01);
Abstract
This invention relates to new inhibitors of butyrylcholinesterase with general formulas I and II, where substituents are described in patent description. Compounds can be in the form of pure enantiomers or as racemic mixtures, or in the form of pharmaceutically acceptable salts. The present invention relates to the use of these inhibitors for the treatment of Alzheimer's disease and other forms of dementia.